In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders

Ongoing advances in pharmaceutical biotechnology have paved the way to ground-breaking new biological therapeutic modalities, offering the possibility of a durable curative approach for a number of life-threatening diseases, for which the medical need is as yet unmet. Over the past decades, gene the...

Full description

Saved in:
Bibliographic Details
Other Authors: Bachtarzi, Houria (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2019
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_130783
005 20231201
003 oapen
006 m o d
007 cr|mn|---annan
008 20231201s2019 xx |||||o ||| 0|eng d
020 |a intechopen.72962 
020 |a 9781789857184 
020 |a 9781789857177 
020 |a 9781839620829 
040 |a oapen  |c oapen 
024 7 |a 10.5772/intechopen.72962  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MFN  |2 bicssc 
100 1 |a Bachtarzi, Houria  |4 edt 
700 1 |a Bachtarzi, Houria  |4 oth 
245 1 0 |a In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders 
260 |b IntechOpen  |c 2019 
300 |a 1 electronic resource (198 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Ongoing advances in pharmaceutical biotechnology have paved the way to ground-breaking new biological therapeutic modalities, offering the possibility of a durable curative approach for a number of life-threatening diseases, for which the medical need is as yet unmet. Over the past decades, gene therapy has seen a massive transformation from a proof-of-concept approach to a clinical reality culminating in the regulatory approval of state-of-the-art products in the European Union and in the United States. This book captures some of the scientific progresses notably in gene transfer technologies and translational development of in vivo and ex vivo gene therapy interventions in the treatment of a broad range of complex and debilitating non-inherited and inherited disorders such as: human immunodeficiency virus 1 (HIV-1) infection, cancer, cystic fibrosis, hereditary retinopathies, haemophilia B, cardiac diseases, and chronic liver fibrosis. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Medical genetics  |2 bicssc 
653 |a nanoparticles, heart failure, drug delivery, vaccine, hiv, cardiomyopathy 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/6788/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/130783  |7 0  |z DOAB: description of the publication